Global Pneumococcal Vaccine Market Size, Manufacturers, Opportunities and Forecast to 2030
Summary
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.
23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).
According to APO Research, The global Pneumococcal Vaccine market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Pneumococcal Vaccine include Pfizer, GSK, MSD, Sanofipasteur and CDIBP, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pneumococcal Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumococcal Vaccine.
The Pneumococcal Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pneumococcal Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pneumococcal Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pneumococcal Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pneumococcal Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pneumococcal Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Pneumococcal Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.
23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).
According to APO Research, The global Pneumococcal Vaccine market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Pneumococcal Vaccine include Pfizer, GSK, MSD, Sanofipasteur and CDIBP, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pneumococcal Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumococcal Vaccine.
The Pneumococcal Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pneumococcal Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Pfizer
- GSK
- MSD
- Sanofipasteur
- CDIBP
- PPSV 23
- PCV 7/13
- PCV 10
- Child
- Adult
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pneumococcal Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pneumococcal Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pneumococcal Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pneumococcal Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Pneumococcal Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Pneumococcal Vaccine Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Pneumococcal Vaccine Sales Estimates and Forecasts (2019-2030)
1.3 Pneumococcal Vaccine Market by Type
1.3.1 PPSV
1.3.2 PCV 7/13
1.3.3 PCV
1.4 Global Pneumococcal Vaccine Market Size by Type
1.4.1 Global Pneumococcal Vaccine Market Size Overview by Type (2019-2030)
1.4.2 Global Pneumococcal Vaccine Historic Market Size Review by Type (2019-2024)
1.4.3 Global Pneumococcal Vaccine Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Pneumococcal Vaccine Sales Breakdown by Type (2019-2024)
1.5.2 Europe Pneumococcal Vaccine Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Pneumococcal Vaccine Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Pneumococcal Vaccine Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Pneumococcal Vaccine Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Pneumococcal Vaccine Industry Trends
2.2 Pneumococcal Vaccine Industry Drivers
2.3 Pneumococcal Vaccine Industry Opportunities and Challenges
2.4 Pneumococcal Vaccine Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Pneumococcal Vaccine Revenue (2019-2024)
3.2 Global Top Players by Pneumococcal Vaccine Sales (2019-2024)
3.3 Global Top Players by Pneumococcal Vaccine Price (2019-2024)
3.4 Global Pneumococcal Vaccine Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Pneumococcal Vaccine Key Company Manufacturing Sites & Headquarters
3.6 Global Pneumococcal Vaccine Company, Product Type & Application
3.7 Global Pneumococcal Vaccine Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Pneumococcal Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Pneumococcal Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Pneumococcal Vaccine Tier 1, Tier 2, and Tier
4 PNEUMOCOCCAL VACCINE REGIONAL STATUS AND OUTLOOK
4.1 Global Pneumococcal Vaccine Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Pneumococcal Vaccine Historic Market Size by Region
4.2.1 Global Pneumococcal Vaccine Sales in Volume by Region (2019-2024)
4.2.2 Global Pneumococcal Vaccine Sales in Value by Region (2019-2024)
4.2.3 Global Pneumococcal Vaccine Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Pneumococcal Vaccine Forecasted Market Size by Region
4.3.1 Global Pneumococcal Vaccine Sales in Volume by Region (2025-2030)
4.3.2 Global Pneumococcal Vaccine Sales in Value by Region (2025-2030)
4.3.3 Global Pneumococcal Vaccine Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 PNEUMOCOCCAL VACCINE BY APPLICATION
5.1 Pneumococcal Vaccine Market by End User
5.1.1 Child
5.1.2 Adult
5.2 Global Pneumococcal Vaccine Market Size by End User
5.2.1 Global Pneumococcal Vaccine Market Size Overview by Application (2019-2030)
5.2.2 Global Pneumococcal Vaccine Historic Market Size Review by Application (2019-2024)
5.2.3 Global Pneumococcal Vaccine Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by End User
5.3.1 North America Pneumococcal Vaccine Sales Breakdown by End User (2019-2024)
5.3.2 Europe Pneumococcal Vaccine Sales Breakdown by End User (2019-2024)
5.3.3 Asia-Pacific Pneumococcal Vaccine Sales Breakdown by End User (2019-2024)
5.3.4 Latin America Pneumococcal Vaccine Sales Breakdown by End User (2019-2024)
5.3.5 Middle East and Africa Pneumococcal Vaccine Sales Breakdown by End User (2019-2024)
6 COMPANY PROFILES
6.1 Pfizer
6.1.1 Pfizer Comapny Information
6.1.2 Pfizer Business Overview
6.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Pneumococcal Vaccine Product Portfolio
6.1.5 Pfizer Recent Developments
6.2 GSK
6.2.1 GSK Comapny Information
6.2.2 GSK Business Overview
6.2.3 GSK Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Pneumococcal Vaccine Product Portfolio
6.2.5 GSK Recent Developments
6.3 MSD
6.3.1 MSD Comapny Information
6.3.2 MSD Business Overview
6.3.3 MSD Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 MSD Pneumococcal Vaccine Product Portfolio
6.3.5 MSD Recent Developments
6.4 Sanofipasteur
6.4.1 Sanofipasteur Comapny Information
6.4.2 Sanofipasteur Business Overview
6.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofipasteur Pneumococcal Vaccine Product Portfolio
6.4.5 Sanofipasteur Recent Developments
6.5 CDIBP
6.5.1 CDIBP Comapny Information
6.5.2 CDIBP Business Overview
6.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CDIBP Pneumococcal Vaccine Product Portfolio
6.5.5 CDIBP Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Pneumococcal Vaccine Sales by Country
7.1.1 North America Pneumococcal Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Pneumococcal Vaccine Sales by Country (2019-2024)
7.1.3 North America Pneumococcal Vaccine Sales Forecast by Country (2025-2030)
7.2 North America Pneumococcal Vaccine Market Size by Country
7.2.1 North America Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Pneumococcal Vaccine Market Size by Country (2019-2024)
7.2.3 North America Pneumococcal Vaccine Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Pneumococcal Vaccine Sales by Country
8.1.1 Europe Pneumococcal Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Pneumococcal Vaccine Sales by Country (2019-2024)
8.1.3 Europe Pneumococcal Vaccine Sales Forecast by Country (2025-2030)
8.2 Europe Pneumococcal Vaccine Market Size by Country
8.2.1 Europe Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Pneumococcal Vaccine Market Size by Country (2019-2024)
8.2.3 Europe Pneumococcal Vaccine Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Pneumococcal Vaccine Sales by Country
9.1.1 Asia-Pacific Pneumococcal Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Pneumococcal Vaccine Sales by Country (2019-2024)
9.1.3 Asia-Pacific Pneumococcal Vaccine Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Pneumococcal Vaccine Market Size by Country
9.2.1 Asia-Pacific Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Pneumococcal Vaccine Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Pneumococcal Vaccine Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Pneumococcal Vaccine Sales by Country
10.1.1 Latin America Pneumococcal Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Pneumococcal Vaccine Sales by Country (2019-2024)
10.1.3 Latin America Pneumococcal Vaccine Sales Forecast by Country (2025-2030)
10.2 Latin America Pneumococcal Vaccine Market Size by Country
10.2.1 Latin America Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Pneumococcal Vaccine Market Size by Country (2019-2024)
10.2.3 Latin America Pneumococcal Vaccine Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Pneumococcal Vaccine Sales by Country
11.1.1 Middle East and Africa Pneumococcal Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Pneumococcal Vaccine Sales by Country (2019-2024)
11.1.3 Middle East and Africa Pneumococcal Vaccine Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Pneumococcal Vaccine Market Size by Country
11.2.1 Middle East and Africa Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Pneumococcal Vaccine Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Pneumococcal Vaccine Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Pneumococcal Vaccine Value Chain Analysis
12.1.1 Pneumococcal Vaccine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Pneumococcal Vaccine Production Mode & Process
12.2 Pneumococcal Vaccine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Pneumococcal Vaccine Distributors
12.2.3 Pneumococcal Vaccine Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Pneumococcal Vaccine Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Pneumococcal Vaccine Sales Estimates and Forecasts (2019-2030)
1.3 Pneumococcal Vaccine Market by Type
1.3.1 PPSV
1.3.2 PCV 7/13
1.3.3 PCV
1.4 Global Pneumococcal Vaccine Market Size by Type
1.4.1 Global Pneumococcal Vaccine Market Size Overview by Type (2019-2030)
1.4.2 Global Pneumococcal Vaccine Historic Market Size Review by Type (2019-2024)
1.4.3 Global Pneumococcal Vaccine Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Pneumococcal Vaccine Sales Breakdown by Type (2019-2024)
1.5.2 Europe Pneumococcal Vaccine Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Pneumococcal Vaccine Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Pneumococcal Vaccine Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Pneumococcal Vaccine Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Pneumococcal Vaccine Industry Trends
2.2 Pneumococcal Vaccine Industry Drivers
2.3 Pneumococcal Vaccine Industry Opportunities and Challenges
2.4 Pneumococcal Vaccine Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Pneumococcal Vaccine Revenue (2019-2024)
3.2 Global Top Players by Pneumococcal Vaccine Sales (2019-2024)
3.3 Global Top Players by Pneumococcal Vaccine Price (2019-2024)
3.4 Global Pneumococcal Vaccine Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Pneumococcal Vaccine Key Company Manufacturing Sites & Headquarters
3.6 Global Pneumococcal Vaccine Company, Product Type & Application
3.7 Global Pneumococcal Vaccine Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Pneumococcal Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Pneumococcal Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Pneumococcal Vaccine Tier 1, Tier 2, and Tier
4 PNEUMOCOCCAL VACCINE REGIONAL STATUS AND OUTLOOK
4.1 Global Pneumococcal Vaccine Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Pneumococcal Vaccine Historic Market Size by Region
4.2.1 Global Pneumococcal Vaccine Sales in Volume by Region (2019-2024)
4.2.2 Global Pneumococcal Vaccine Sales in Value by Region (2019-2024)
4.2.3 Global Pneumococcal Vaccine Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Pneumococcal Vaccine Forecasted Market Size by Region
4.3.1 Global Pneumococcal Vaccine Sales in Volume by Region (2025-2030)
4.3.2 Global Pneumococcal Vaccine Sales in Value by Region (2025-2030)
4.3.3 Global Pneumococcal Vaccine Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 PNEUMOCOCCAL VACCINE BY APPLICATION
5.1 Pneumococcal Vaccine Market by End User
5.1.1 Child
5.1.2 Adult
5.2 Global Pneumococcal Vaccine Market Size by End User
5.2.1 Global Pneumococcal Vaccine Market Size Overview by Application (2019-2030)
5.2.2 Global Pneumococcal Vaccine Historic Market Size Review by Application (2019-2024)
5.2.3 Global Pneumococcal Vaccine Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by End User
5.3.1 North America Pneumococcal Vaccine Sales Breakdown by End User (2019-2024)
5.3.2 Europe Pneumococcal Vaccine Sales Breakdown by End User (2019-2024)
5.3.3 Asia-Pacific Pneumococcal Vaccine Sales Breakdown by End User (2019-2024)
5.3.4 Latin America Pneumococcal Vaccine Sales Breakdown by End User (2019-2024)
5.3.5 Middle East and Africa Pneumococcal Vaccine Sales Breakdown by End User (2019-2024)
6 COMPANY PROFILES
6.1 Pfizer
6.1.1 Pfizer Comapny Information
6.1.2 Pfizer Business Overview
6.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Pneumococcal Vaccine Product Portfolio
6.1.5 Pfizer Recent Developments
6.2 GSK
6.2.1 GSK Comapny Information
6.2.2 GSK Business Overview
6.2.3 GSK Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Pneumococcal Vaccine Product Portfolio
6.2.5 GSK Recent Developments
6.3 MSD
6.3.1 MSD Comapny Information
6.3.2 MSD Business Overview
6.3.3 MSD Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 MSD Pneumococcal Vaccine Product Portfolio
6.3.5 MSD Recent Developments
6.4 Sanofipasteur
6.4.1 Sanofipasteur Comapny Information
6.4.2 Sanofipasteur Business Overview
6.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofipasteur Pneumococcal Vaccine Product Portfolio
6.4.5 Sanofipasteur Recent Developments
6.5 CDIBP
6.5.1 CDIBP Comapny Information
6.5.2 CDIBP Business Overview
6.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CDIBP Pneumococcal Vaccine Product Portfolio
6.5.5 CDIBP Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Pneumococcal Vaccine Sales by Country
7.1.1 North America Pneumococcal Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Pneumococcal Vaccine Sales by Country (2019-2024)
7.1.3 North America Pneumococcal Vaccine Sales Forecast by Country (2025-2030)
7.2 North America Pneumococcal Vaccine Market Size by Country
7.2.1 North America Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Pneumococcal Vaccine Market Size by Country (2019-2024)
7.2.3 North America Pneumococcal Vaccine Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Pneumococcal Vaccine Sales by Country
8.1.1 Europe Pneumococcal Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Pneumococcal Vaccine Sales by Country (2019-2024)
8.1.3 Europe Pneumococcal Vaccine Sales Forecast by Country (2025-2030)
8.2 Europe Pneumococcal Vaccine Market Size by Country
8.2.1 Europe Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Pneumococcal Vaccine Market Size by Country (2019-2024)
8.2.3 Europe Pneumococcal Vaccine Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Pneumococcal Vaccine Sales by Country
9.1.1 Asia-Pacific Pneumococcal Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Pneumococcal Vaccine Sales by Country (2019-2024)
9.1.3 Asia-Pacific Pneumococcal Vaccine Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Pneumococcal Vaccine Market Size by Country
9.2.1 Asia-Pacific Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Pneumococcal Vaccine Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Pneumococcal Vaccine Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Pneumococcal Vaccine Sales by Country
10.1.1 Latin America Pneumococcal Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Pneumococcal Vaccine Sales by Country (2019-2024)
10.1.3 Latin America Pneumococcal Vaccine Sales Forecast by Country (2025-2030)
10.2 Latin America Pneumococcal Vaccine Market Size by Country
10.2.1 Latin America Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Pneumococcal Vaccine Market Size by Country (2019-2024)
10.2.3 Latin America Pneumococcal Vaccine Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Pneumococcal Vaccine Sales by Country
11.1.1 Middle East and Africa Pneumococcal Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Pneumococcal Vaccine Sales by Country (2019-2024)
11.1.3 Middle East and Africa Pneumococcal Vaccine Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Pneumococcal Vaccine Market Size by Country
11.2.1 Middle East and Africa Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Pneumococcal Vaccine Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Pneumococcal Vaccine Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Pneumococcal Vaccine Value Chain Analysis
12.1.1 Pneumococcal Vaccine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Pneumococcal Vaccine Production Mode & Process
12.2 Pneumococcal Vaccine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Pneumococcal Vaccine Distributors
12.2.3 Pneumococcal Vaccine Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
LIST OF TABLES
Table 1. Major Company of PPSV 23
Table 2. Major Company of PCV 7/13
Table 3. Major Company of PCV 10
Table 4. Global Pneumococcal Vaccine Sales by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 5. Global Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 6. Global Pneumococcal Vaccine Sales Market Share in Volume by Type (2019-2024)
Table 7. Global Pneumococcal Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 8. Global Pneumococcal Vaccine Sales Market Share in Value by Type (2019-2024)
Table 9. Global Pneumococcal Vaccine Price by Type (2019-2024) & (USD/Dose)
Table 10. Global Pneumococcal Vaccine Sales by Type (2025-2030) & (K Doses)
Table 11. Global Pneumococcal Vaccine Sales Market Share in Volume by Type (2025-2030)
Table 12. Global Pneumococcal Vaccine Sales by Type (2025-2030) & (US$ Million)
Table 13. Global Pneumococcal Vaccine Sales Market Share in Value by Type (2025-2030)
Table 14. Global Pneumococcal Vaccine Price by Type (2025-2030) & (USD/Dose)
Table 15. North America Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 16. North America Pneumococcal Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 17. Europe Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 18. Europe Pneumococcal Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 19. Asia-Pacific Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 20. Asia-Pacific Pneumococcal Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 21. Latin America Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 22. Latin America Pneumococcal Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 23. Middle East and Africa Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 24. Middle East and Africa Pneumococcal Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 25. Pneumococcal Vaccine Industry Trends
Table 26. Pneumococcal Vaccine Industry Drivers
Table 27. Pneumococcal Vaccine Industry Opportunities and Challenges
Table 28. Pneumococcal Vaccine Industry Restraints
Table 29. Global Pneumococcal Vaccine Sales Revenue by Company (US$ Million) & (2019-2024)
Table 30. Global Pneumococcal Vaccine Revenue Market Share by Company (2019-2024)
Table 31. Global Pneumococcal Vaccine Sales by Company (2019-2024) & (K Doses)
Table 32. Global Pneumococcal Vaccine Sales Share by Company (2019-2024)
Table 33. Global Pneumococcal Vaccine Market Price by Company (2019-2024) & (USD/Dose)
Table 34. Global Pneumococcal Vaccine Industry Company Ranking, 2022 VS 2023 VS 2024
Table 35. Global Pneumococcal Vaccine Key Company Manufacturing Sites & Headquarters
Table 36. Global Pneumococcal Vaccine Company, Product Type & Application
Table 37. Global Pneumococcal Vaccine Company Commercialization Time
Table 38. Global Company Market Concentration Ratio (CR5 and HHI)
Table 39. Global Pneumococcal Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 40. Global Pneumococcal Vaccine Market Size Comparison by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Global Pneumococcal Vaccine Sales by Region (2019-2024) & (K Doses)
Table 42. Global Pneumococcal Vaccine Sales Market Share in Volume by Region (2019-2024)
Table 43. Global Pneumococcal Vaccine Sales by Region (2019-2024) & (US$ Million)
Table 44. Global Pneumococcal Vaccine Sales Market Share in Value by Region (2019-2024)
Table 45. Global Pneumococcal Vaccine Sales (K Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 46. Global Pneumococcal Vaccine Sales by Region (2025-2030) & (K Doses)
Table 47. Global Pneumococcal Vaccine Sales Market Share in Volume by Region (2025-2030)
Table 48. Global Pneumococcal Vaccine Sales by Region (2025-2030) & (US$ Million)
Table 49. Global Pneumococcal Vaccine Sales Market Share in Value by Region (2025-2030)
Table 50. Global Pneumococcal Vaccine Sales (K Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2025-2030)
Table 51. Global Pneumococcal Vaccine Sales by End User (2019 VS 2023 VS 2030) & (US$ Million)
Table 52. Global Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 53. Global Pneumococcal Vaccine Sales Market Share in Volume by End User (2019-2024)
Table 54. Global Pneumococcal Vaccine Sales by End User (2019-2024) & (US$ Million)
Table 55. Global Pneumococcal Vaccine Sales Market Share in Value by End User (2019-2024)
Table 56. Global Pneumococcal Vaccine Price by End User (2019-2024) & (USD/Dose)
Table 57. Global Pneumococcal Vaccine Sales by End User (2025-2030) & (K Doses)
Table 58. Global Pneumococcal Vaccine Sales Market Share in Volume by End User (2025-2030)
Table 59. Global Pneumococcal Vaccine Sales by End User (2025-2030) & (US$ Million)
Table 60. Global Pneumococcal Vaccine Sales Market Share in Value by End User (2025-2030)
Table 61. Global Pneumococcal Vaccine Price by End User (2025-2030) & (USD/Dose)
Table 62. North America Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 63. North America Pneumococcal Vaccine Sales by End User (2019-2024) & (US$ Million)
Table 64. Europe Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 65. Europe Pneumococcal Vaccine Sales by End User (2019-2024) & (US$ Million)
Table 66. Asia-Pacific Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 67. Asia-Pacific Pneumococcal Vaccine Sales by End User (2019-2024) & (US$ Million)
Table 68. Latin America Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 69. Latin America Pneumococcal Vaccine Sales by End User (2019-2024) & (US$ Million)
Table 70. Middle East and Africa Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 71. Middle East and Africa Pneumococcal Vaccine Sales by End User (2019-2024) & (US$ Million)
Table 72. Pfizer Company Information
Table 73. Pfizer Business Overview
Table 74. Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 75. Pfizer Pneumococcal Vaccine Product Portfolio
Table 76. Pfizer Recent Development
Table 77. GSK Company Information
Table 78. GSK Business Overview
Table 79. GSK Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 80. GSK Pneumococcal Vaccine Product Portfolio
Table 81. GSK Recent Development
Table 82. MSD Company Information
Table 83. MSD Business Overview
Table 84. MSD Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 85. MSD Pneumococcal Vaccine Product Portfolio
Table 86. MSD Recent Development
Table 87. Sanofipasteur Company Information
Table 88. Sanofipasteur Business Overview
Table 89. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 90. Sanofipasteur Pneumococcal Vaccine Product Portfolio
Table 91. Sanofipasteur Recent Development
Table 92. CDIBP Company Information
Table 93. CDIBP Business Overview
Table 94. CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 95. CDIBP Pneumococcal Vaccine Product Portfolio
Table 96. CDIBP Recent Development
Table 97. North America Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (K Doses): 2019 VS 2023 VS 2030
Table 98. North America Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 99. North America Pneumococcal Vaccine Sales Market Share by Country (2019-2024)
Table 100. North America Pneumococcal Vaccine Sales Forecast by Country (2025-2030) & (K Doses)
Table 101. North America Pneumococcal Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 102. North America Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 103. North America Pneumococcal Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 104. North America Pneumococcal Vaccine Market Share by Country (2019-2024)
Table 105. North America Pneumococcal Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 106. North America Pneumococcal Vaccine Market Share Forecast by Country (2025-2030)
Table 107. Europe Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (K Doses): 2019 VS 2023 VS 2030
Table 108. Europe Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 109. Europe Pneumococcal Vaccine Sales Market Share by Country (2019-2024)
Table 110. Europe Pneumococcal Vaccine Sales Forecast by Country (2025-2030) & (K Doses)
Table 111. Europe Pneumococcal Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 112. Europe Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 113. Europe Pneumococcal Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 114. Europe Pneumococcal Vaccine Market Share by Country (2019-2024)
Table 115. Europe Pneumococcal Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 116. Europe Pneumococcal Vaccine Market Share Forecast by Country (2025-2030)
Table 117. Asia-Pacific Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (K Doses): 2019 VS 2023 VS 2030
Table 118. Asia-Pacific Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 119. Asia-Pacific Pneumococcal Vaccine Sales Market Share by Country (2019-2024)
Table 120. Asia-Pacific Pneumococcal Vaccine Sales Forecast by Country (2025-2030) & (K Doses)
Table 121. Asia-Pacific Pneumococcal Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 122. Asia-Pacific Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 123. Asia-Pacific Pneumococcal Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 124. Asia-Pacific Pneumococcal Vaccine Market Share by Country (2019-2024)
Table 125. Asia-Pacific Pneumococcal Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 126. Asia-Pacific Pneumococcal Vaccine Market Share Forecast by Country (2025-2030)
Table 127. Latin America Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (K Doses): 2019 VS 2023 VS 2030
Table 128. Latin America Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 129. Latin America Pneumococcal Vaccine Sales Market Share by Country (2019-2024)
Table 130. Latin America Pneumococcal Vaccine Sales Forecast by Country (2025-2030) & (K Doses)
Table 131. Latin America Pneumococcal Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 132. Latin America Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 133. Latin America Pneumococcal Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 134. Latin America Pneumococcal Vaccine Market Share by Country (2019-2024)
Table 135. Latin America Pneumococcal Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 136. Latin America Pneumococcal Vaccine Market Share Forecast by Country (2025-2030)
Table 137. Middle East and Africa Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (K Doses): 2019 VS 2023 VS 2030
Table 138. Middle East and Africa Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 139. Middle East and Africa Pneumococcal Vaccine Sales Market Share by Country (2019-2024)
Table 140. Middle East and Africa Pneumococcal Vaccine Sales Forecast by Country (2025-2030) & (K Doses)
Table 141. Middle East and Africa Pneumococcal Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 142. Middle East and Africa Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 143. Middle East and Africa Pneumococcal Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 144. Middle East and Africa Pneumococcal Vaccine Market Share by Country (2019-2024)
Table 145. Middle East and Africa Pneumococcal Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 146. Middle East and Africa Pneumococcal Vaccine Market Share Forecast by Country (2025-2030)
Table 147. Key Raw Materials
Table 148. Raw Materials Key Suppliers
Table 149. Pneumococcal Vaccine Distributors List
Table 150. Pneumococcal Vaccine Customers List
Table 151. Research Programs/Design for This Report
Table 152. Authors List of This Report
Table 153. Secondary Sources
Table 154. Primary Sources
Table 1. Major Company of PPSV 23
Table 2. Major Company of PCV 7/13
Table 3. Major Company of PCV 10
Table 4. Global Pneumococcal Vaccine Sales by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 5. Global Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 6. Global Pneumococcal Vaccine Sales Market Share in Volume by Type (2019-2024)
Table 7. Global Pneumococcal Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 8. Global Pneumococcal Vaccine Sales Market Share in Value by Type (2019-2024)
Table 9. Global Pneumococcal Vaccine Price by Type (2019-2024) & (USD/Dose)
Table 10. Global Pneumococcal Vaccine Sales by Type (2025-2030) & (K Doses)
Table 11. Global Pneumococcal Vaccine Sales Market Share in Volume by Type (2025-2030)
Table 12. Global Pneumococcal Vaccine Sales by Type (2025-2030) & (US$ Million)
Table 13. Global Pneumococcal Vaccine Sales Market Share in Value by Type (2025-2030)
Table 14. Global Pneumococcal Vaccine Price by Type (2025-2030) & (USD/Dose)
Table 15. North America Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 16. North America Pneumococcal Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 17. Europe Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 18. Europe Pneumococcal Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 19. Asia-Pacific Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 20. Asia-Pacific Pneumococcal Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 21. Latin America Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 22. Latin America Pneumococcal Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 23. Middle East and Africa Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 24. Middle East and Africa Pneumococcal Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 25. Pneumococcal Vaccine Industry Trends
Table 26. Pneumococcal Vaccine Industry Drivers
Table 27. Pneumococcal Vaccine Industry Opportunities and Challenges
Table 28. Pneumococcal Vaccine Industry Restraints
Table 29. Global Pneumococcal Vaccine Sales Revenue by Company (US$ Million) & (2019-2024)
Table 30. Global Pneumococcal Vaccine Revenue Market Share by Company (2019-2024)
Table 31. Global Pneumococcal Vaccine Sales by Company (2019-2024) & (K Doses)
Table 32. Global Pneumococcal Vaccine Sales Share by Company (2019-2024)
Table 33. Global Pneumococcal Vaccine Market Price by Company (2019-2024) & (USD/Dose)
Table 34. Global Pneumococcal Vaccine Industry Company Ranking, 2022 VS 2023 VS 2024
Table 35. Global Pneumococcal Vaccine Key Company Manufacturing Sites & Headquarters
Table 36. Global Pneumococcal Vaccine Company, Product Type & Application
Table 37. Global Pneumococcal Vaccine Company Commercialization Time
Table 38. Global Company Market Concentration Ratio (CR5 and HHI)
Table 39. Global Pneumococcal Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 40. Global Pneumococcal Vaccine Market Size Comparison by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Global Pneumococcal Vaccine Sales by Region (2019-2024) & (K Doses)
Table 42. Global Pneumococcal Vaccine Sales Market Share in Volume by Region (2019-2024)
Table 43. Global Pneumococcal Vaccine Sales by Region (2019-2024) & (US$ Million)
Table 44. Global Pneumococcal Vaccine Sales Market Share in Value by Region (2019-2024)
Table 45. Global Pneumococcal Vaccine Sales (K Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 46. Global Pneumococcal Vaccine Sales by Region (2025-2030) & (K Doses)
Table 47. Global Pneumococcal Vaccine Sales Market Share in Volume by Region (2025-2030)
Table 48. Global Pneumococcal Vaccine Sales by Region (2025-2030) & (US$ Million)
Table 49. Global Pneumococcal Vaccine Sales Market Share in Value by Region (2025-2030)
Table 50. Global Pneumococcal Vaccine Sales (K Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2025-2030)
Table 51. Global Pneumococcal Vaccine Sales by End User (2019 VS 2023 VS 2030) & (US$ Million)
Table 52. Global Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 53. Global Pneumococcal Vaccine Sales Market Share in Volume by End User (2019-2024)
Table 54. Global Pneumococcal Vaccine Sales by End User (2019-2024) & (US$ Million)
Table 55. Global Pneumococcal Vaccine Sales Market Share in Value by End User (2019-2024)
Table 56. Global Pneumococcal Vaccine Price by End User (2019-2024) & (USD/Dose)
Table 57. Global Pneumococcal Vaccine Sales by End User (2025-2030) & (K Doses)
Table 58. Global Pneumococcal Vaccine Sales Market Share in Volume by End User (2025-2030)
Table 59. Global Pneumococcal Vaccine Sales by End User (2025-2030) & (US$ Million)
Table 60. Global Pneumococcal Vaccine Sales Market Share in Value by End User (2025-2030)
Table 61. Global Pneumococcal Vaccine Price by End User (2025-2030) & (USD/Dose)
Table 62. North America Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 63. North America Pneumococcal Vaccine Sales by End User (2019-2024) & (US$ Million)
Table 64. Europe Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 65. Europe Pneumococcal Vaccine Sales by End User (2019-2024) & (US$ Million)
Table 66. Asia-Pacific Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 67. Asia-Pacific Pneumococcal Vaccine Sales by End User (2019-2024) & (US$ Million)
Table 68. Latin America Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 69. Latin America Pneumococcal Vaccine Sales by End User (2019-2024) & (US$ Million)
Table 70. Middle East and Africa Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 71. Middle East and Africa Pneumococcal Vaccine Sales by End User (2019-2024) & (US$ Million)
Table 72. Pfizer Company Information
Table 73. Pfizer Business Overview
Table 74. Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 75. Pfizer Pneumococcal Vaccine Product Portfolio
Table 76. Pfizer Recent Development
Table 77. GSK Company Information
Table 78. GSK Business Overview
Table 79. GSK Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 80. GSK Pneumococcal Vaccine Product Portfolio
Table 81. GSK Recent Development
Table 82. MSD Company Information
Table 83. MSD Business Overview
Table 84. MSD Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 85. MSD Pneumococcal Vaccine Product Portfolio
Table 86. MSD Recent Development
Table 87. Sanofipasteur Company Information
Table 88. Sanofipasteur Business Overview
Table 89. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 90. Sanofipasteur Pneumococcal Vaccine Product Portfolio
Table 91. Sanofipasteur Recent Development
Table 92. CDIBP Company Information
Table 93. CDIBP Business Overview
Table 94. CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 95. CDIBP Pneumococcal Vaccine Product Portfolio
Table 96. CDIBP Recent Development
Table 97. North America Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (K Doses): 2019 VS 2023 VS 2030
Table 98. North America Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 99. North America Pneumococcal Vaccine Sales Market Share by Country (2019-2024)
Table 100. North America Pneumococcal Vaccine Sales Forecast by Country (2025-2030) & (K Doses)
Table 101. North America Pneumococcal Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 102. North America Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 103. North America Pneumococcal Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 104. North America Pneumococcal Vaccine Market Share by Country (2019-2024)
Table 105. North America Pneumococcal Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 106. North America Pneumococcal Vaccine Market Share Forecast by Country (2025-2030)
Table 107. Europe Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (K Doses): 2019 VS 2023 VS 2030
Table 108. Europe Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 109. Europe Pneumococcal Vaccine Sales Market Share by Country (2019-2024)
Table 110. Europe Pneumococcal Vaccine Sales Forecast by Country (2025-2030) & (K Doses)
Table 111. Europe Pneumococcal Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 112. Europe Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 113. Europe Pneumococcal Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 114. Europe Pneumococcal Vaccine Market Share by Country (2019-2024)
Table 115. Europe Pneumococcal Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 116. Europe Pneumococcal Vaccine Market Share Forecast by Country (2025-2030)
Table 117. Asia-Pacific Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (K Doses): 2019 VS 2023 VS 2030
Table 118. Asia-Pacific Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 119. Asia-Pacific Pneumococcal Vaccine Sales Market Share by Country (2019-2024)
Table 120. Asia-Pacific Pneumococcal Vaccine Sales Forecast by Country (2025-2030) & (K Doses)
Table 121. Asia-Pacific Pneumococcal Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 122. Asia-Pacific Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 123. Asia-Pacific Pneumococcal Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 124. Asia-Pacific Pneumococcal Vaccine Market Share by Country (2019-2024)
Table 125. Asia-Pacific Pneumococcal Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 126. Asia-Pacific Pneumococcal Vaccine Market Share Forecast by Country (2025-2030)
Table 127. Latin America Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (K Doses): 2019 VS 2023 VS 2030
Table 128. Latin America Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 129. Latin America Pneumococcal Vaccine Sales Market Share by Country (2019-2024)
Table 130. Latin America Pneumococcal Vaccine Sales Forecast by Country (2025-2030) & (K Doses)
Table 131. Latin America Pneumococcal Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 132. Latin America Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 133. Latin America Pneumococcal Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 134. Latin America Pneumococcal Vaccine Market Share by Country (2019-2024)
Table 135. Latin America Pneumococcal Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 136. Latin America Pneumococcal Vaccine Market Share Forecast by Country (2025-2030)
Table 137. Middle East and Africa Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (K Doses): 2019 VS 2023 VS 2030
Table 138. Middle East and Africa Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 139. Middle East and Africa Pneumococcal Vaccine Sales Market Share by Country (2019-2024)
Table 140. Middle East and Africa Pneumococcal Vaccine Sales Forecast by Country (2025-2030) & (K Doses)
Table 141. Middle East and Africa Pneumococcal Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 142. Middle East and Africa Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 143. Middle East and Africa Pneumococcal Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 144. Middle East and Africa Pneumococcal Vaccine Market Share by Country (2019-2024)
Table 145. Middle East and Africa Pneumococcal Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 146. Middle East and Africa Pneumococcal Vaccine Market Share Forecast by Country (2025-2030)
Table 147. Key Raw Materials
Table 148. Raw Materials Key Suppliers
Table 149. Pneumococcal Vaccine Distributors List
Table 150. Pneumococcal Vaccine Customers List
Table 151. Research Programs/Design for This Report
Table 152. Authors List of This Report
Table 153. Secondary Sources
Table 154. Primary Sources
LIST OF FIGURES
Figure 1. Pneumococcal Vaccine Product Picture
Figure 2. Global Pneumococcal Vaccine Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Pneumococcal Vaccine Market Size (2019-2030) & (US$ Million)
Figure 4. Global Pneumococcal Vaccine Sales (2019-2030) & (K Doses)
Figure 5. Product Picture of PPSV 23
Figure 6. Global PPSV 23 Sales YoY Growth (2019-2030) & (K Doses)
Figure 7. Product Picture of PCV 7/13
Figure 8. Global PCV 7/13 Sales YoY Growth (2019-2030) & (K Doses)
Figure 9. Product Picture of PCV 10
Figure 10. Global PCV 10 Sales YoY Growth (2019-2030) & (K Doses)
Figure 11. Global Pneumococcal Vaccine Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 12. Global Pneumococcal Vaccine Market Share by Type 2023 VS 2030
Figure 13. North America Pneumococcal Vaccine Sales Market Share in Volume by Type in 2023
Figure 14. North America Pneumococcal Vaccine Sales Market Share in Value by Type in 2023
Figure 15. Europe Pneumococcal Vaccine Sales Market Share in Volume by Type in 2023
Figure 16. Europe Pneumococcal Vaccine Sales Market Share in Value by Type in 2023
Figure 17. Asia-Pacific Pneumococcal Vaccine Sales Market Share in Volume by Type in 2023
Figure 18. Asia-Pacific Pneumococcal Vaccine Sales Market Share in Value by Type in 2023
Figure 19. Latin America Pneumococcal Vaccine Sales Market Share in Volume by Type in 2023
Figure 20. Latin America Pneumococcal Vaccine Sales Market Share in Value by Type in 2023
Figure 21. Middle East and Africa Pneumococcal Vaccine Sales Market Share in Volume by Type in 2023
Figure 22. Middle East and Africa Pneumococcal Vaccine Sales Market Share in Value by Type in 2023
Figure 23. Global Top 5 and 10 Pneumococcal Vaccine Players Market Share by Revenue in 2023
Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 25. Product Picture of Child
Figure 26. Global Child Sales YoY Growth (2019-2030) & (K Doses)
Figure 27. Product Picture of Adult
Figure 28. Global Adult Sales YoY Growth (2019-2030) & (K Doses)
Figure 29. Global Pneumococcal Vaccine Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 30. Global Pneumococcal Vaccine Market Share by Application 2023 VS 2030
Figure 31. North America Pneumococcal Vaccine Sales Market Share in Volume by Application in 2023
Figure 32. North America Pneumococcal Vaccine Sales Market Share in Value by Application in 2023
Figure 33. Europe Pneumococcal Vaccine Sales Market Share in Volume by Application in 2023
Figure 34. Europe Pneumococcal Vaccine Sales Market Share in Value by Application in 2023
Figure 35. Asia-Pacific Pneumococcal Vaccine Sales Market Share in Volume by Application in 2023
Figure 36. Asia-Pacific Pneumococcal Vaccine Sales Market Share in Value by Application in 2023
Figure 37. Latin America Pneumococcal Vaccine Sales Market Share in Volume by Application in 2023
Figure 38. Latin America Pneumococcal Vaccine Sales Market Share in Value by Application in 2023
Figure 39. Middle East and Africa Pneumococcal Vaccine Sales Market Share in Volume by Application in 2023
Figure 40. Middle East and Africa Pneumococcal Vaccine Sales Market Share in Value by Application in 2023
Figure 41. North America Pneumococcal Vaccine Sales by Country: 2019 VS 2023 VS 2030 (K Doses)
Figure 42. North America Pneumococcal Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 43. North America Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 44. North America Pneumococcal Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 45. Europe Pneumococcal Vaccine Sales by Country: 2019 VS 2023 VS 2030 (K Doses)
Figure 46. Europe Pneumococcal Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 47. Europe Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 48. Europe Pneumococcal Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 49. Asia-Pacific Pneumococcal Vaccine Sales by Country: 2019 VS 2023 VS 2030 (K Doses)
Figure 50. Asia-Pacific Pneumococcal Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 51. Asia-Pacific Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 52. Asia-Pacific Pneumococcal Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 53. Latin America Pneumococcal Vaccine Sales by Country: 2019 VS 2023 VS 2030 (K Doses)
Figure 54. Latin America Pneumococcal Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 55. Latin America Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 56. Latin America Pneumococcal Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 57. Middle East and Africa Pneumococcal Vaccine Sales by Country: 2019 VS 2023 VS 2030 (K Doses)
Figure 58. Middle East and Africa Pneumococcal Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 59. Middle East and Africa Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 60. Middle East and Africa Pneumococcal Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 61. Pneumococcal Vaccine Value Chain
Figure 62. Key Raw Materials Price
Figure 63. Manufacturing Cost Structure
Figure 64. Pneumococcal Vaccine Production Mode & Process
Figure 65. Direct Comparison with Distribution Share
Figure 66. Distributors Profiles
Figure 67. Years Considered
Figure 68. Research Process
Figure 69. Key Executives Interviewed
Figure 1. Pneumococcal Vaccine Product Picture
Figure 2. Global Pneumococcal Vaccine Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Pneumococcal Vaccine Market Size (2019-2030) & (US$ Million)
Figure 4. Global Pneumococcal Vaccine Sales (2019-2030) & (K Doses)
Figure 5. Product Picture of PPSV 23
Figure 6. Global PPSV 23 Sales YoY Growth (2019-2030) & (K Doses)
Figure 7. Product Picture of PCV 7/13
Figure 8. Global PCV 7/13 Sales YoY Growth (2019-2030) & (K Doses)
Figure 9. Product Picture of PCV 10
Figure 10. Global PCV 10 Sales YoY Growth (2019-2030) & (K Doses)
Figure 11. Global Pneumococcal Vaccine Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 12. Global Pneumococcal Vaccine Market Share by Type 2023 VS 2030
Figure 13. North America Pneumococcal Vaccine Sales Market Share in Volume by Type in 2023
Figure 14. North America Pneumococcal Vaccine Sales Market Share in Value by Type in 2023
Figure 15. Europe Pneumococcal Vaccine Sales Market Share in Volume by Type in 2023
Figure 16. Europe Pneumococcal Vaccine Sales Market Share in Value by Type in 2023
Figure 17. Asia-Pacific Pneumococcal Vaccine Sales Market Share in Volume by Type in 2023
Figure 18. Asia-Pacific Pneumococcal Vaccine Sales Market Share in Value by Type in 2023
Figure 19. Latin America Pneumococcal Vaccine Sales Market Share in Volume by Type in 2023
Figure 20. Latin America Pneumococcal Vaccine Sales Market Share in Value by Type in 2023
Figure 21. Middle East and Africa Pneumococcal Vaccine Sales Market Share in Volume by Type in 2023
Figure 22. Middle East and Africa Pneumococcal Vaccine Sales Market Share in Value by Type in 2023
Figure 23. Global Top 5 and 10 Pneumococcal Vaccine Players Market Share by Revenue in 2023
Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 25. Product Picture of Child
Figure 26. Global Child Sales YoY Growth (2019-2030) & (K Doses)
Figure 27. Product Picture of Adult
Figure 28. Global Adult Sales YoY Growth (2019-2030) & (K Doses)
Figure 29. Global Pneumococcal Vaccine Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 30. Global Pneumococcal Vaccine Market Share by Application 2023 VS 2030
Figure 31. North America Pneumococcal Vaccine Sales Market Share in Volume by Application in 2023
Figure 32. North America Pneumococcal Vaccine Sales Market Share in Value by Application in 2023
Figure 33. Europe Pneumococcal Vaccine Sales Market Share in Volume by Application in 2023
Figure 34. Europe Pneumococcal Vaccine Sales Market Share in Value by Application in 2023
Figure 35. Asia-Pacific Pneumococcal Vaccine Sales Market Share in Volume by Application in 2023
Figure 36. Asia-Pacific Pneumococcal Vaccine Sales Market Share in Value by Application in 2023
Figure 37. Latin America Pneumococcal Vaccine Sales Market Share in Volume by Application in 2023
Figure 38. Latin America Pneumococcal Vaccine Sales Market Share in Value by Application in 2023
Figure 39. Middle East and Africa Pneumococcal Vaccine Sales Market Share in Volume by Application in 2023
Figure 40. Middle East and Africa Pneumococcal Vaccine Sales Market Share in Value by Application in 2023
Figure 41. North America Pneumococcal Vaccine Sales by Country: 2019 VS 2023 VS 2030 (K Doses)
Figure 42. North America Pneumococcal Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 43. North America Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 44. North America Pneumococcal Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 45. Europe Pneumococcal Vaccine Sales by Country: 2019 VS 2023 VS 2030 (K Doses)
Figure 46. Europe Pneumococcal Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 47. Europe Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 48. Europe Pneumococcal Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 49. Asia-Pacific Pneumococcal Vaccine Sales by Country: 2019 VS 2023 VS 2030 (K Doses)
Figure 50. Asia-Pacific Pneumococcal Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 51. Asia-Pacific Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 52. Asia-Pacific Pneumococcal Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 53. Latin America Pneumococcal Vaccine Sales by Country: 2019 VS 2023 VS 2030 (K Doses)
Figure 54. Latin America Pneumococcal Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 55. Latin America Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 56. Latin America Pneumococcal Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 57. Middle East and Africa Pneumococcal Vaccine Sales by Country: 2019 VS 2023 VS 2030 (K Doses)
Figure 58. Middle East and Africa Pneumococcal Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 59. Middle East and Africa Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 60. Middle East and Africa Pneumococcal Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 61. Pneumococcal Vaccine Value Chain
Figure 62. Key Raw Materials Price
Figure 63. Manufacturing Cost Structure
Figure 64. Pneumococcal Vaccine Production Mode & Process
Figure 65. Direct Comparison with Distribution Share
Figure 66. Distributors Profiles
Figure 67. Years Considered
Figure 68. Research Process
Figure 69. Key Executives Interviewed
